Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-107363
Filing Date
2016-06-07
Accepted
2016-06-07 19:26:21
Documents
1
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v441929_3.html 3  
1 OWNERSHIP DOCUMENT v441929_3.xml 3 1532
  Complete submission text file 0001144204-16-107363.txt   2904
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2575 W. BELLFORT SUITE 333 HOUSTON TX 77054
Business Address
Northcut Jacqueline (Reporting) CIK: 0001674644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37758 | Film No.: 161702464